Hanmi Science Co., Ltd. (KRX:008930)
South Korea · Delayed Price · Currency is KRW 49,700
-300 (-0.60%)
At close: Jul 25, 2025, 3:30 PM KST
Hanmi Science Company Description
Hanmi Science Co., Ltd., through its subsidiaries, manufactures and sells pharmaceutical products in Korea and internationally.
It develops drugs in the areas of diabetes and anti-cancer, as well as children's and adult’s bowel preparation and cold medicines, and cephalosporin antibiotics.
The company also offers general foods, health functional foods, soy milk, and medical equipment. In addition, it offers automated drug management systems.
The company sells its products through online and offline pharmacies. The company was formerly known as Hanmi Holdings Co., Ltd. and changed its name to Hanmi Science Co., Ltd. in March 2012.
Hanmi Science Co., Ltd. was founded in 1973 and is headquartered in Seoul, South Korea.
Hanmi Science Co., Ltd.
| Country | South Korea |
| Founded | 1973 |
| Industry | Medical Distribution |
| Sector | Healthcare |
| Employees | 444 |
| CEO | Jong-Hoon Lim |
Contact Details
Address: 14 Wiryeseong-daero Seoul, 05545 South Korea | |
| Phone | 82 2 410 9114 |
| Website | hanmiscience.co.kr |
Stock Details
| Ticker Symbol | 008930 |
| Exchange | Korea Stock Exchange |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | KRW |
| ISIN Number | KR7008930000 |
| SIC Code | 5122 |
Key Executives
| Name | Position |
|---|---|
| Jong-Hoon Lim | Chief Executive Officer |
| Ju-Hyun Lim | President and Inside Director |
| Chan Seob Kim | Chief Financial Officer and Senior MD |